×
For best experience we recommend to activate Javascript in your browser.
Recombinant IL12B (Ebdarokimab Biosimilar) antibody
This anti-IL12B (Ebdarokimab Biosimilar) antibody is a Human Monoclonal antibody detecting IL12B (Ebdarokimab Biosimilar) in ELISA, BLI, FACS, Func and SPR. Suitable for Human.
Quick Overview for Recombinant IL12B (Ebdarokimab Biosimilar) antibody (ABIN7581470)
Target
IL12B (Ebdarokimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for IL12B (Ebdarokimab Biosimilar) antibodies
Human
Clonality
All clonalities for IL12B (Ebdarokimab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for IL12B (Ebdarokimab Biosimilar) antibodies
This IL12B (Ebdarokimab Biosimilar) antibody is un-conjugated
Application
ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
Product Details anti-IL12B (Ebdarokimab Biosimilar) Antibody
(hide)
Expression System
CHO Cells
Purpose
Anti-IL-12b Reference Antibody (ebdarokimab)
Characteristics
Anti-IL-12b Reference Antibody (ebdarokimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Purity
>95 %
Isotype
IgG1
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Concentration
1 mg/mL
Buffer
25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
Storage
4 °C,-80 °C
Storage Comment
+4°C,-80°C
Target Details for IL12B (Ebdarokimab Biosimilar)
(hide)
Target
IL12B (Ebdarokimab Biosimilar)
Alternative Name
IL-12b (Ebdarokimab Biosimilar)
Target Type
Biosimilar
Molecular Weight
145.5 kDa
UniProt
P29460
Recently viewed
(hide)
Chat with us , powered by LiveChat